Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Performances of Urine and Plasma 5HIAA Values in Small-intestine Neuroendocrine Tumors
NCT02826928Completed
- Sponsor
- CHU de Reims
- Start
- Oct 2016
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by CHU de Reims. Primary endpoint: Urine 5-hydroxyindolacetic acid value at 24 hours. Started Oct 2016; status: completed.
Beyond the preview
Go deeper on NCT02826928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826928.